BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 32410676)

  • 1. Availability, prices, and affordability of selected essential cancer medicines in a middle-income country - the case of Mexico.
    Moye-Holz D; Ewen M; Dreser A; Bautista-Arredondo S; Soria-Saucedo R; van Dijk JP; Reijneveld SA; Hogerzeil HV
    BMC Health Serv Res; 2020 May; 20(1):424. PubMed ID: 32410676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon.
    Abdel Rida N; Mohamed Ibrahim MI; Babar ZUD
    BMC Health Serv Res; 2019 Dec; 19(1):973. PubMed ID: 31852546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
    Ewen M; Zweekhorst M; Regeer B; Laing R
    PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Availability, prices and affordability of selected essential medicines in Jordan: a national survey.
    Alefan Q; Amairi R; Tawalbeh S
    BMC Health Serv Res; 2018 Oct; 18(1):787. PubMed ID: 30340486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
    Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
    PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prices, availability and affordability of medicines in Rwanda.
    Bizimana T; Kayumba PC; Heide L
    PLoS One; 2020; 15(8):e0236411. PubMed ID: 32745100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access to essential cardiovascular medicines for children: a pilot study of availability, price and affordability in Nigeria.
    Orubu ESF; Robert FO; Samuel M; Megbule D
    Health Policy Plan; 2019 Dec; 34(Supplement_3):iii20-iii26. PubMed ID: 31816074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China.
    Zhu Y; Wang Y; Sun X; Li X
    Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31623326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia.
    Kaiser AH; Hehman L; Forsberg BC; Simangolwa WM; Sundewall J
    PLoS One; 2019; 14(12):e0226169. PubMed ID: 31834889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
    Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
    Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China.
    Yang H; Dib HH; Zhu M; Qi G; Zhang X
    Health Policy Plan; 2010 May; 25(3):219-29. PubMed ID: 19955093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating essential medicines for treating childhood cancers: availability, price and affordability study in Ghana.
    Mensah KB; Mensah ABB; Bangalee V; Padayachee N; Oosthuizen F
    BMC Cancer; 2021 Jun; 21(1):683. PubMed ID: 34112117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Where are we now: assessing the price, availability and affordability of essential medicines in Delhi as India plans free medicine for all.
    Kotwani A
    BMC Health Serv Res; 2013 Jul; 13():285. PubMed ID: 23885985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India.
    Satheesh G; Sharma A; Puthean S; Ansil T P M; E J; Raj Mishra S; Unnikrishnan MK
    Trop Med Int Health; 2020 Dec; 25(12):1467-1479. PubMed ID: 32959441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
    Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
    J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide survey of the availability and affordability of asthma and COPD medicines in Nigeria.
    Ozoh OB; Eze JN; Garba BI; Ojo OO; Okorie EM; Yiltok E; Okoli CV; Hammangabdo A; Beran D
    Trop Med Int Health; 2021 Jan; 26(1):54-65. PubMed ID: 32985028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.
    Osuafor NG; Ukwe CV; Okonta M
    PLoS One; 2021; 16(8):e0255567. PubMed ID: 34383799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are essential medicines in Malaysia accessible, affordable and available?
    Saleh K; Ibrahim MI
    Pharm World Sci; 2005 Dec; 27(6):442-6. PubMed ID: 16341951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access and Affordability of Medicines in Malaysia: Need for a National Pricing Policy.
    Wong SL; Ibrahim S; Abdul Kadir N; Mohd Salleh S
    Appl Health Econ Health Policy; 2019 Oct; 17(5):641-654. PubMed ID: 31093937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Availability, prices and affordability of essential medicines in Zhejiang Province, China.
    Dong Z; Tao Q; Yan B; Sun G
    PLoS One; 2020; 15(11):e0241761. PubMed ID: 33232336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.